Class information for:
Level 1: SUPERFICIAL BLADDER CANCER//NON MUSCLE INVASIVE BLADDER CANCER//BACILLUS CALMETTE GUERIN

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
447 3381 27.8 72%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
335 17284 BLADDER CANCER//CYSTECTOMY//URINARY DIVERSION

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 SUPERFICIAL BLADDER CANCER Author keyword 179 70% 4% 147
2 NON MUSCLE INVASIVE BLADDER CANCER Author keyword 127 69% 3% 107
3 BACILLUS CALMETTE GUERIN Author keyword 121 49% 5% 181
4 INTRAVESICAL CHEMOTHERAPY Author keyword 113 76% 2% 78
5 INTRAVESICAL THERAPY Author keyword 92 64% 3% 90
6 BLADDER NEOPLASMS Author keyword 77 22% 9% 313
7 BLADDER CANCER Author keyword 63 10% 18% 594
8 BCG VACCINE Author keyword 59 37% 4% 126
9 BCG Author keyword 56 21% 7% 235
10 T1G3 Author keyword 41 90% 1% 18

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 SUPERFICIAL BLADDER CANCER 179 70% 4% 147 Search SUPERFICIAL+BLADDER+CANCER Search SUPERFICIAL+BLADDER+CANCER
2 NON MUSCLE INVASIVE BLADDER CANCER 127 69% 3% 107 Search NON+MUSCLE+INVASIVE+BLADDER+CANCER Search NON+MUSCLE+INVASIVE+BLADDER+CANCER
3 BACILLUS CALMETTE GUERIN 121 49% 5% 181 Search BACILLUS+CALMETTE+GUERIN Search BACILLUS+CALMETTE+GUERIN
4 INTRAVESICAL CHEMOTHERAPY 113 76% 2% 78 Search INTRAVESICAL+CHEMOTHERAPY Search INTRAVESICAL+CHEMOTHERAPY
5 INTRAVESICAL THERAPY 92 64% 3% 90 Search INTRAVESICAL+THERAPY Search INTRAVESICAL+THERAPY
6 BLADDER NEOPLASMS 77 22% 9% 313 Search BLADDER+NEOPLASMS Search BLADDER+NEOPLASMS
7 BLADDER CANCER 63 10% 18% 594 Search BLADDER+CANCER Search BLADDER+CANCER
8 BCG VACCINE 59 37% 4% 126 Search BCG+VACCINE Search BCG+VACCINE
9 BCG 56 21% 7% 235 Search BCG Search BCG
10 T1G3 41 90% 1% 18 Search T1G3 Search T1G3

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 BACILLUS CALMETTE GUERIN 271 30% 23% 761
2 STAGE TA 185 74% 4% 139
3 STAGE T1 149 88% 2% 69
4 SUPERFICIAL BLADDER CANCER 140 40% 8% 273
5 TRANSITIONAL CELL CARCINOMA 136 14% 26% 886
6 INTRAVESICAL THERAPY 125 65% 4% 119
7 WHITE LIGHT CYSTOSCOPY 117 76% 2% 81
8 BCG IMMUNOTHERAPY 89 60% 3% 97
9 IMMEDIATE POSTOPERATIVE INSTILLATION 77 89% 1% 34
10 TRANSURETHRAL RESECTION 76 21% 9% 319

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder 2008 350 48 83%
The mechanism of action of BCG therapy for bladder cancer-a current perspective 2014 16 104 87%
Recurrence and Progression of Disease in Non-Muscle-Invasive Bladder Cancer: From Epidemiology to Treatment Strategy 2009 145 130 81%
ICUD-EAU International Consultation on Bladder Cancer 2012: Non-Muscle-Invasive Urothelial Carcinoma of the Bladder 2013 38 44 89%
A Review of Current Guidelines and Best Practice Recommendations for the Management of Nonmuscle Invasive Bladder Cancer by the International Bladder Cancer Group 2011 60 38 100%
Diagnosis and Management of Urothelial Carcinoma In Situ of the Lower Urinary Tract: A Systematic Review 2015 2 106 76%
Photodynamic Diagnosis in Non-Muscle-Invasive Bladder Cancer: A Systematic Review and Cumulative Analysis of Prospective Studies 2010 73 43 86%
Intravesical therapy for superficial bladder cancer: A systematic review of randomised trials and meta-analyses 2010 60 49 100%
Defining Progression in Nonmuscle Invasive Bladder Cancer: It is Time for a New, Standard Definition 2014 6 39 100%
Bacillus Calmette-Guerin (BCG) immunotherapy for bladder cancer: Current understanding and perspectives on engineered BCG vaccine 2013 29 61 80%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 BCG ONCOL 12 86% 0.2% 6
2 FUNDACIO PUIGVERT 4 17% 0.7% 23
3 DEF MED BUR 3 100% 0.1% 3
4 CENT PHARMACOVIGILANCE 2 67% 0.1% 2
5 EMI 99 09 2 67% 0.1% 2
6 PHARMACOL ANALYT 2 67% 0.1% 2
7 RUCT HOSP 2 67% 0.1% 2
8 SIDNEY KIMMEL 2 67% 0.1% 2
9 ZFKM 2 43% 0.1% 3
10 HUMAN EXPT PATHOL 1 31% 0.1% 4

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000150245 NMP22//UROVYSION//URINE CYTOLOGY
2 0.0000125051 PROSTATE SPARING//CYSTOPROSTATECTOMY//RADICAL CYSTOPROSTATECTOMY
3 0.0000117670 COMPUTER BASED CLASSIFICATION//BLADDER WASHING//TRANSITIONAL CELL BLADDER CANCER
4 0.0000116349 FGFR3//GENES P53//DBCCR1
5 0.0000090184 BLADDER PRESERVATION//BLADDER CANCER//CYSTECTOMY
6 0.0000069532 WHO ABORAT FOOD NUTR POLICIES//STUDIES MED PROGRAMS SERV//COMPLEX GENET
7 0.0000066659 MULTIPLE NEUROFIBROMATOSIS//INTRASCROTAL//MALIGNANT NEUROFIBROMA
8 0.0000063764 VIRTUAL CYSTOSCOPY//BLADDER NEOPLASMS STAGING//BLADDER NEOPLASMS CT
9 0.0000059286 NEPHROURETERECTOMY//UPPER URINARY TRACT//UPPER TRACT UROTHELIAL CARCINOMA
10 0.0000049459 Z 100//BCG VIABILITY//NATURAL IMMUNOMODULATOR